The MHIP ETF aims to outperform healthcare cost inflation over the long term, using Milliman actuarial analysis that reflects medical spending trends among users of US employer-sponsored health insurance. Rather than relying solely on stocks in a single industry, it is an actively managed structure that combines multiple asset classes with a quantitative model.

It suits investors who want to manage the risk of rising healthcare costs as a separate factor and who can tolerate the volatility of an actively managed strategy that includes non-equity assets.

It is an ETF with an active management approach, run by Milliman Financial Risk Management.

This strategy targets performance linked to US healthcare cost inflation, as measured by proprietary actuarial analysis, and combines the healthcare sector with several asset classes. The model can adjust asset allocation to reflect market conditions and risk factors, but neither the targeted correlation nor any outperformance is guaranteed.

• Goal setting based on medical claims data and actuarial analysis
• Active management that combines multiple asset classes with a quantitative model

Assets under management (AUM) stand at $1.6M, and the expense ratio is 0.55% per year.

Because the liquidity of this product can vary with market conditions, it is worth checking the bid-ask spread and any gap between the market price and net asset value before trading. Beyond the fee level, the actual operating characteristics of the model-based strategy also deserve scrutiny.

The strategy's performance can be shaped jointly by upward pressure on healthcare costs and movements in the stock, bond, and commodity markets. Linkage to healthcare cost inflation is the core objective, but depending on asset price swings and model decisions, short-term performance may diverge from the target indicator.

Fund flows may be influenced by demand from investors who want to manage healthcare cost risk separately within a portfolio, as well as by interest rates, commodities, and conditions in the healthcare sector. Because the product structure permits multi-asset allocation and the use of derivatives, shifts in risk appetite during volatile markets may be reflected in trading conditions.

Its clear objective of addressing healthcare cost inflation and its multi-asset management are strengths, but investors must also accept model risk, correlation risk, sector risk, and derivatives risk.

Because information on comparable listed funds is limited, when comparing with other products it is worth first checking how each one links to healthcare cost inflation, how concentrated it is in the healthcare sector, and the range of stocks, bonds, commodities, and derivatives it uses, rather than looking only at fee levels. Differences in whether a fund is actively managed, in trading conditions, and in distribution policy should also be reviewed to see whether they fit a long-term holding purpose.

When considering the MHIP ETF, first confirm that the goal of addressing healthcare cost inflation matches your own risk management purpose. Given the nature of multi-asset and model-driven management, an approach that looks at costs, correlation, trading conditions, and sector sensitivity together is needed.

The quantitative model may fail to capture healthcare cost inflation accurately, or changes in asset allocation may produce unexpected results. Changes in healthcare regulation and cost structures, movements in interest rates and commodity prices, and the complexity of derivatives can also be factors that increase losses and volatility.

The MHIP ETF is a product worth considering for those seeking a multi-asset strategy focused on the risk of rising healthcare costs. However, investors should understand that it has no distribution history and is managed on a model basis, and should confirm that its linkage to healthcare cost indicators, its costs, liquidity, and market risk fit their own holding purpose.